Addus HomeCare (NASDAQ:ADUS) Upgraded at Citizens Jmp

Citizens Jmp upgraded shares of Addus HomeCare (NASDAQ:ADUS) to a strong-buy rating in a research report report published on Monday morning,Zacks.com reports.

Several other analysts also recently weighed in on ADUS. JMP Securities began coverage on Addus HomeCare in a research note on Monday. They issued an “outperform” rating and a $150.00 price target on the stock. Macquarie reaffirmed an “outperform” rating and issued a $139.00 price target on shares of Addus HomeCare in a research report on Monday, November 4th. KeyCorp started coverage on shares of Addus HomeCare in a research note on Friday, October 11th. They issued an “overweight” rating and a $150.00 price target on the stock. Oppenheimer lifted their target price on shares of Addus HomeCare from $140.00 to $145.00 and gave the stock an “outperform” rating in a report on Monday, September 23rd. Finally, Royal Bank of Canada reissued an “outperform” rating and set a $136.00 price target on shares of Addus HomeCare in a research report on Thursday, November 14th. One analyst has rated the stock with a sell rating, nine have given a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, Addus HomeCare currently has a consensus rating of “Buy” and an average price target of $133.67.

Addus HomeCare Trading Down 0.7 %

NASDAQ:ADUS opened at $129.75 on Monday. Addus HomeCare has a 12 month low of $85.94 and a 12 month high of $136.12. The company has a 50-day moving average price of $125.79 and a 200-day moving average price of $124.80. The stock has a market cap of $2.35 billion, a price-to-earnings ratio of 29.69, a P/E/G ratio of 2.11 and a beta of 1.01.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings results on Monday, November 4th. The company reported $1.30 earnings per share for the quarter, beating the consensus estimate of $1.28 by $0.02. The company had revenue of $289.80 million for the quarter, compared to analyst estimates of $289.42 million. Addus HomeCare had a return on equity of 9.62% and a net margin of 6.50%. The firm’s revenue was up 7.1% on a year-over-year basis. During the same period in the previous year, the company posted $1.03 earnings per share. Equities analysts forecast that Addus HomeCare will post 4.59 EPS for the current fiscal year.

Insider Activity

In related news, CEO R Dirk Allison sold 12,500 shares of the stock in a transaction dated Monday, November 25th. The shares were sold at an average price of $123.16, for a total value of $1,539,500.00. Following the completion of the transaction, the chief executive officer now owns 141,897 shares of the company’s stock, valued at approximately $17,476,034.52. This trade represents a 8.10 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, EVP Roberton James Stevenson sold 2,250 shares of the business’s stock in a transaction that occurred on Monday, December 9th. The stock was sold at an average price of $121.00, for a total value of $272,250.00. Following the sale, the executive vice president now directly owns 10,217 shares in the company, valued at $1,236,257. The trade was a 18.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Company insiders own 4.60% of the company’s stock.

Institutional Investors Weigh In On Addus HomeCare

Several large investors have recently added to or reduced their stakes in ADUS. Franklin Resources Inc. boosted its holdings in shares of Addus HomeCare by 2.7% in the third quarter. Franklin Resources Inc. now owns 26,216 shares of the company’s stock valued at $3,456,000 after purchasing an additional 701 shares during the period. Hohimer Wealth Management LLC purchased a new position in shares of Addus HomeCare during the third quarter valued at $299,000. Geode Capital Management LLC raised its holdings in shares of Addus HomeCare by 7.1% in the third quarter. Geode Capital Management LLC now owns 423,934 shares of the company’s stock valued at $56,406,000 after acquiring an additional 28,284 shares in the last quarter. Barclays PLC lifted its stake in Addus HomeCare by 204.8% in the third quarter. Barclays PLC now owns 43,470 shares of the company’s stock worth $5,783,000 after acquiring an additional 29,207 shares during the period. Finally, EP Wealth Advisors LLC bought a new position in Addus HomeCare during the 3rd quarter worth about $249,000. 95.35% of the stock is owned by hedge funds and other institutional investors.

About Addus HomeCare

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.